An NIH-funded collaboration involving ISCRM researchers has published a study describing how complementary areas of expertise produced new insights about hypertrophic cardiomyopathy at the protein, cell, and tissue levels. Read More
New data presented by ISCRM Director Chuck Murry suggests gene-editing may be the key to clearing a major hurdle for researchers hoping to remuscularize injured hearts with stem cell-derived cardiomyocytes Read More
ISCRM investigators use rainbow cell technology to demonstrate that injected heart cells proliferate, a finding that could help researchers enhance the efficacy of cell therapy for heart disease and other conditions. Read More
With a Collaborative Science Award from the American Heart Association Jen Davis, Farid Moussavi-Harami , and Tom Daniel are on a mission to develop new tools to help cardiologists personalize treatments for certain heart diseases too. Read More
Nearly 18 million people die each year from heart disease, making it the leading cause of death in the world. In the United States alone, the annual economic impact of heart disease exceeds $200 billion, a figure that is expected to rise dramatically. Read More
UW geneticists have recently come across a discovery that can possibly help alleviate the high prevalence of heart disease, which could have profound implications in the field of medicine. Researchers, […] Read More